$2.70—Stale · unknown old
SET • Last print unknown ago
$2.70—Stale · unknown old
Bio Science Animal Health Public Company Limited (BIS.BK) is a leading player in the packaged foods sector, specializing in animal health products across Thailand and Southeast Asia. The company focuses on providing high-quality nutritional supplements and veterinary pharmaceuticals, leveraging its strong distribution network and established relationships with local farmers and veterinarians.
BIS.BK generates revenue primarily through the sale of animal health products, which are essential for livestock management. The company benefits from a strong brand reputation and established distribution channels, allowing it to maintain pricing power despite competitive pressures. Its focus on research and development enables the introduction of innovative products that meet evolving market needs.
Changes in livestock health trends impacting demand for nutritional supplements
Regulatory changes affecting veterinary pharmaceuticals
Fluctuations in raw material prices for animal feed
Market expansion into neighboring Southeast Asian countries
Regulatory changes in animal health standards that could affect product approval processes
Technological advancements in animal health that could disrupt existing product lines
Increased competition from local and international players offering similar products
Potential price wars driven by new entrants in the market
Low liquidity risk due to a strong current ratio of 2.67
Potential risks associated with currency fluctuations in Southeast Asian markets
moderate - The company's performance is somewhat linked to agricultural output and consumer spending on animal health, which can be influenced by economic conditions.
Interest rates have minimal direct impact on BIS.BK's operations; however, higher rates could affect consumer spending and agricultural investment, indirectly influencing demand for its products.
minimal - The company has a very low debt-to-equity ratio, indicating limited reliance on external financing.
value - Investors may be attracted to the low price-to-earnings and price-to-book ratios, indicating potential undervaluation.
moderate - The stock has shown some volatility, with a 1-year return of -12.0%, reflecting market uncertainties.